H. Jeffrey Lawrence

8.3k total citations
57 papers, 4.8k citations indexed

About

H. Jeffrey Lawrence is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Jeffrey Lawrence has authored 57 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 17 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Jeffrey Lawrence's work include Developmental Biology and Gene Regulation (14 papers), Cancer-related gene regulation (11 papers) and Epigenetics and DNA Methylation (7 papers). H. Jeffrey Lawrence is often cited by papers focused on Developmental Biology and Gene Regulation (14 papers), Cancer-related gene regulation (11 papers) and Epigenetics and DNA Methylation (7 papers). H. Jeffrey Lawrence collaborates with scholars based in United States, Canada and Spain. H. Jeffrey Lawrence's co-authors include Corey Largman, R. Keith Humphries, Guy Sauvageau, Peter M. Lansdorp, Unnur Þorsteinsdóttir, Connie J. Eaves, Cheryl D. Helgason, Wieslawa H. Dragowska, Wei-Fang Shen and Stephen S. Fong and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

H. Jeffrey Lawrence

56 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Jeffrey Lawrence United States 33 3.4k 1.3k 885 706 662 57 4.8k
Merav Socolovsky United States 30 2.5k 0.7× 1.1k 0.8× 974 1.1× 428 0.6× 840 1.3× 52 4.4k
Susannah Waxman United States 33 2.9k 0.8× 1.5k 1.2× 501 0.6× 621 0.9× 368 0.6× 97 4.0k
John F. Lyons United States 32 2.7k 0.8× 577 0.4× 1.3k 1.5× 308 0.4× 347 0.5× 81 4.3k
Max Chaffanet France 36 2.4k 0.7× 953 0.7× 1.5k 1.7× 531 0.8× 377 0.6× 105 4.4k
Myriam Alcalay Italy 41 5.5k 1.6× 3.5k 2.6× 787 0.9× 789 1.1× 604 0.9× 86 6.4k
Dennis K. Watson United States 41 3.6k 1.0× 591 0.4× 1.3k 1.4× 567 0.8× 904 1.4× 106 5.8k
Teresa Palomero United States 29 3.5k 1.0× 1.1k 0.8× 1.0k 1.2× 204 0.3× 872 1.3× 61 5.4k
Fausto Grignani Italy 20 3.0k 0.9× 1.2k 0.9× 677 0.8× 503 0.7× 508 0.8× 50 3.8k
Stany Chrétien France 29 1.9k 0.6× 873 0.7× 970 1.1× 251 0.4× 638 1.0× 64 3.4k
Hanna S. Radomska United States 29 2.4k 0.7× 1.6k 1.2× 455 0.5× 371 0.5× 866 1.3× 58 3.7k

Countries citing papers authored by H. Jeffrey Lawrence

Since Specialization
Citations

This map shows the geographic impact of H. Jeffrey Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Jeffrey Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Jeffrey Lawrence more than expected).

Fields of papers citing papers by H. Jeffrey Lawrence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Jeffrey Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Jeffrey Lawrence. The network helps show where H. Jeffrey Lawrence may publish in the future.

Co-authorship network of co-authors of H. Jeffrey Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of H. Jeffrey Lawrence. A scholar is included among the top collaborators of H. Jeffrey Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Jeffrey Lawrence. H. Jeffrey Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López‐Ríos, Fernando, Bárbara Angulo, Rebeca Martínez, et al.. (2013). Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer. Journal of Clinical Pathology. 66(5). 381–385. 43 indexed citations
2.
López‐Ríos, Fernando, Bárbara Angulo, Rebeca Martínez, et al.. (2013). Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for Vemurafenib. PLoS ONE. 8(1). e53733–e53733. 38 indexed citations
3.
Sauvageau, Guy, Unnur Thorsteinsdottir, Aline Mamo, et al.. (2013). marrow cells induces stem cell expansion associatedHoxa9 gene in bone - Overexpression of the myeloid leukemia.
4.
Shah, Sweta, Stephen Soviero, Rachel Langland, et al.. (2012). Analytical Performance of a Real-time PCR-based Assay for V600 Mutations in the BRAF Gene, Used as the Companion Diagnostic Test for the Novel BRAF Inhibitor Vemurafenib in Metastatic Melanoma. Diagnostic Molecular Pathology. 21(1). 1–8. 117 indexed citations
5.
Anderson, Steven M., Kenneth J. Bloom, Josef Rueschoff, et al.. (2012). Multisite Analytic Performance Studies of a Real-Time Polymerase Chain Reaction Assay for the Detection of BRAF V600E Mutations in Formalin-Fixed, Paraffin-Embedded Tissue Specimens of Malignant Melanoma. Archives of Pathology & Laboratory Medicine. 136(11). 1385–1391. 113 indexed citations
6.
Castro, David González de, Roberto Martínez, Felice Shieh, et al.. (2011). PP 28 Analytical performance and workflow comparison study of three methods for detecting KRAS mutations in formalin-fixed paraffin-embedded tissue (FFPET) specimens of colorectal cancer (CRC). European Journal of Cancer. 47. S18–S18. 1 indexed citations
7.
Charruyer, Alexandra, et al.. (2009). Transit-Amplifying Cell Frequency and Cell Cycle Kinetics Are Altered in Aged Epidermis. Journal of Investigative Dermatology. 129(11). 2574–2583. 28 indexed citations
8.
Magnusson, Mattias, Ann Brun, H. Jeffrey Lawrence, & Stefan Karlsson. (2007). Hoxa9/hoxb3/hoxb4 compound null mice display severe hematopoietic defects. Experimental Hematology. 35(9). 1421.e1–1421.e9. 29 indexed citations
9.
Lu, Chuanyi M., Joyce Murata‐Collins, Endi Wang, Imran Siddiqi, & H. Jeffrey Lawrence. (2006). Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: Molecular evidence of two separate diseases. American Journal of Hematology. 81(12). 963–968. 9 indexed citations
10.
Lawrence, H. Jeffrey, Julie Anja Engelhard Christensen, Stephen S. Fong, et al.. (2005). Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood. 106(12). 3988–3994. 173 indexed citations
11.
Lawrence, H. Jeffrey, et al.. (2005). HOX genes: not just myeloid oncogenes any more. Leukemia. 19(8). 1328–1330. 7 indexed citations
12.
Pineault, Nicolas, Cheryl D. Helgason, H. Jeffrey Lawrence, & R. Keith Humphries. (2002). Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Experimental Hematology. 30(1). 49–57. 219 indexed citations
13.
Shen, Wei-Fang, Sofia Rozenfeld, H. Jeffrey Lawrence, & Corey Largman. (1997). The Abd-B-like Hox Homeodomain Proteins Can Be Subdivided by the Ability to Form Complexes with Pbx1a on a Novel DNA Target. Journal of Biological Chemistry. 272(13). 8198–8206. 118 indexed citations
14.
Sauvageau, Guy, Unnur Þorsteinsdóttir, Connie J. Eaves, et al.. (1995). Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo.. Genes & Development. 9(14). 1753–1765. 458 indexed citations
15.
Sauvageau, Guy, Peter M. Lansdorp, Connie J. Eaves, et al.. (1994). Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells.. Proceedings of the National Academy of Sciences. 91(25). 12223–12227. 428 indexed citations
16.
Detmer, Kristina, et al.. (1993). Expression of the Hox 2.2 homeobox gene in murine embryonic epidermis. Differentiation. 52(2). 177–184. 20 indexed citations
17.
Lawrence, H. Jeffrey, Kristina Detmer, Robert J. Scibienski, et al.. (1993). Expression of HOX C homeobox genes in lymphoid cells.. PubMed. 4(8). 665–9. 37 indexed citations
18.
Detmer, Kristina, et al.. (1992). Modulation of HOX2 gene expression following differentiation of neuronal cell lines. Differentiation. 51(1). 39–47. 4 indexed citations
19.
Greenberg, Bernard R. & H. Jeffrey Lawrence. (1988). Metastatic Cancer with Unknown Primary. Medical Clinics of North America. 72(5). 1055–1065. 9 indexed citations
20.
Lawrence, H. Jeffrey, et al.. (1982). AMSA--a promising new agent in refractory acute leukemia.. PubMed. 66(7). 1475–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026